Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EscharEx for Debridement of Lower Leg Ulcers
NCT04817228Phase 2Completed
- Sponsor
- MediWound
- Start
- Apr 2021
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of EscharEx in venous leg ulcer (VLU), diabetic foot ulcer (DFU), sponsored by MediWound. Started Apr 2021; status: completed.
02
Drugs
EscharEx
03
Conditions
venous leg ulcer (VLU)diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04817228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04817228.